Lymphocyte trajectories as prognostic indicators in intracerebral hemorrhage: a MIMIC-IV cohort study

Zongren Zhao1, Luming Wei2, Xiaoming Li3

  • 1Department of Neurology, Ulm University, 89081, Ulm, Germany.

Scientific Reports
|December 5, 2025
PubMed

Insights

In patients with spontaneous intracerebral hemorrhage (ICH), a decreasing lymphocyte count trend signals worse outcomes and higher mortality. Identifying these lymphocyte count trajectories aids in risk stratification for better patient management.

Area of Science:

  • Neurology
  • Immunology
  • Critical Care Medicine

Background:

  • Spontaneous intracerebral hemorrhage (ICH) is a critical neurological condition with high mortality.
  • Understanding prognostic markers in ICH is crucial for improving patient outcomes.
  • Lymphocyte counts, indicators of immune status, may offer prognostic insights in ICH.

Purpose of the Study:

  • To investigate the association between lymphocyte count trajectories and clinical outcomes in patients with spontaneous ICH.
  • To identify distinct lymphocyte count patterns and their correlation with mortality and intensive care unit (ICU) length of stay.

Main Methods:

  • Utilized data from the MIMIC-IV database for 841 patients with spontaneous ICH.
  • Employed latent growth mixture modeling to define lymphocyte count trajectory groups.
  • Applied Kaplan-Meier survival analysis and Cox proportional hazards models to assess mortality risk.

Main Results:

  • Identified two distinct lymphocyte count trajectories: increasing (Class 1) and decreasing (Class 2).
  • Class 2 (decreasing lymphocyte count) was significantly associated with lower survival rates (p=0.00046) and higher mortality risk.
  • Patients in Class 2 experienced longer ICU stays (mean 29.83 days vs. 18.34 days) and poorer clinical outcomes.

Conclusions:

  • Lymphocyte count trajectories are significant prognostic indicators in patients with ICH.
  • A decreasing lymphocyte count trend predicts increased mortality and prolonged ICU stays.
  • Early recognition of these lymphocyte patterns can enhance risk stratification and guide therapeutic interventions.